CRSP Exercise Disclosure
Kasinger James R. · SEC Form 4 · Filed Oct 8, 2026
Exercise
Calculated transaction value
$0
Kasinger James R. General Counsel And Secretary
CRSP
Transaction date
Oct 6, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 2 days later
CRSP daily price context
Close on/before transaction
$54
Oct 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Shares
- Quantity / price
- 1,990 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-418101
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$146.58K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crispr Therapeutics Ag CRSP | Exercise | Oct 6, 2026 | $27.1K |
| Crispr Therapeutics Ag CRSP | Sale | Oct 6, 2026 | $119.48K |
| Crispr Therapeutics Ag CRSP Current | Exercise | Oct 6, 2026 | $0 |